ALFA Finder| Revenue growth | 3% YoY growth in FY26; 1% in Q4. |
|---|---|
| Margins | Record levels: Gross Margin 42.3%, EBITDA 19.6%, PAT 16.3% for Q4. |
| Demand visibility | Cautiously optimistic for FY27; dependent on monsoon arrival and distribution. |
| Management confidence | High; described stability in an unstable environment and sustainable record margins. |
Growth
FY26 Revenue grew 3% YoY to ₹3,238cr; PAT rose 7% to ₹543cr; EBITDA margin hit record 20.7%.
Outlook
Ongoing ₹150cr Dahej capex; plans to launch new biostimulant 'Top Grain' and molecules from parent's discovery pipeline.
Risks
Adverse monsoon forecasts (92% of LPA), El Nino probability, and escalating raw material/logistics costs due to geopolitical tensions.
Last quarter's promises, checked
Delivered
- Guided H1 growth → delivered 9% sales & 11% profit growth (= BEAT)
- Guided 4-5 product launches/year → delivered 7 products in FY26 (= BEAT)
- Guided stable pricing despite monsoon → delivered stable pricing YoY (= BEAT)
Partly delivered
- Guided ₹120cr capex commercialization → Bhavnagar complete, Tarapur export delayed (= PARTIAL)
Missed
- Guided robust Q2 performance → delivered slight revenue decline to ₹930cr (= MISS)
Earnings Call filed with NSE, NSE: SUMICHEM. Summary written with AI assistance from the document.
Sumitomo Chemical India Ltd: key numbers
- Share price
- ₹350.95
- Market cap
- ₹17,518 Cr
- Revenue (annual)
- ₹3,238 Cr
- Net profit (annual)
- ₹543.0 Cr
- P/E (TTM)
- 31.3×Sector 35.5×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumitomo Chemical India Ltd
All →Sumitomo Chemical India Earnings Call Transcript: Key Takeaways
Sumitomo Chemical delivered stable H1 performance despite India's fourth weakest monsoon since 2001. Management maintained 20%+ EBITDA margins through cost control and a 22% value growth in specialty products, offsetting volume declines in generic segments.
Sumitomo Chemical India Investor Presentation: Key Takeaways
Q2FY27 revenue Rs907 Cr (-2% YoY), PAT Rs157 Cr (-11%), EBITDA margin 20.5% (-297bps). H1FY27 PAT up 5% to Rs372 Cr on revenue down 1%. Volume-led weakness; inventory cost mismatch hit margins.
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹167.4 Cr, Down 5.8% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹167.4 Cr (-5.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹167.4 Cr · -5.8% YoY
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹157.4 Cr, Down 11.5% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹157.4 Cr (-11.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.4 Cr · -11.5% YoY
Sumitomo Chemical India Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Sumitomo Chemical India Board Meeting Date
Sumitomo Chemical India Limited has scheduled a board meeting for October 26, 2026, to approve the standalone and consolidated financial results for the period ended September 2026.